Emerging linezolid-resistant, vancomycin resistant Enterococcus faecium from a patient of a haematological unit in Poland

Polish Journal of Microbiology

Volumn 53, Issue 3, 2004, Pages 193-196

  Krawczyk, Beata ^a   Samet, Alfred ^b   Bronk, Marek ^b   Hellmann, Andrzej ^c   Kur, Józef ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b Public Hospital No 1   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Allele specific PCR; Enterococcus; Oxazolidinone; PCR; PFGE

Indexed keywords

LINEZOLID; OXAZOLIDINONE DERIVATIVE; RIBOSOME DNA; RIBOSOME RNA; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; DNA DETERMINATION; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; GENE MUTATION; GENETIC ANALYSIS; GRAM POSITIVE BACTERIUM; HEMATOLOGY; HETEROZYGOSITY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POLAND; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ACETAMIDES; ADULT; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; HUMANS; MALE; MUTATION; OXAZOLIDINONES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; VANCOMYCIN RESISTANCE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; POSIBACTERIA;

EID: 6044248857     PISSN: 01371320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Gonzales R.D., P.C. Schreckenberger, M.B. Graham, S. Kelkar, K. DenBesten and J.P. Quinn. 2001. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357: 1179.
2. Herrero I.A., N.C. Issa and R. Patel. 2002. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N. Engl. J. Med. 346: 867-869.
3. Jones R.N., P. Della-Latta, L.V. Lee and D.J. Biedenbach. 2002. Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 42: 137
4. Kloss P., L. Xiong, D.L. Shinabarger and A.S. Mankin. 1999. Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center. J. Mol. Biol. 294: 93-101.
5. Livermore D.M. 2000. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use? J. Antimicrob. Chemother. 46: 347-350.
6. Prystowsky J., F. Siddiqui, J. Chosay, D.L. Shinabarger, J. Millichap, L.R. Peterson and G.A. Noskin. 2001. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 45: 2154-2156.
7. Tsiodras S., H.S. Gold, G. Sakoulas, G.M. Eliopoulos, C. Wennersten, L. Venkataraman, R.C. Moellering and M.J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358: 207-208.
8. Zurenko G., W.M. Todd, B.A. Hafkin, B. Myers, C. Kaufman and J. Bock. 1999. Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid [abstract 848], p. 118. In: Program and abstracts of the 39th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). American Society for Microbiology, Washington, DC.